STEHealthcaresteris.com
| Metric | Dec 2024 | Mar 2025* | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026* | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $1.37B | $1.48B | $1.39B | $1.46B | $1.50B | $1.59B | $1.49B | $1.59B | ▲ +8.8% |
| Gross profit | $610.30M | $641.21M | $628.00M | $645.90M | $655.50M | $697.10M | $684.20M | $710.80M | ▲ +10.0% |
| Operating income | $245.30M | $216.15M | $246.00M | $265.80M | $273.20M | $316.80M | $285.80M | $294.30M | ▲ +10.7% |
| Net income | $173.50M | $145.67M | $177.40M | $191.90M | $192.90M | $220.10M | $200.10M | $213.70M | ▲ +11.4% |
| R&D | $27.40M | $27.69M | $26.40M | $28.20M | $29.50M | $28.80M | $28.60M | $31.50M | ▲ +11.7% |
| EPS (diluted) | 1.75 $ | — | 1.79 $ | 1.94 $ | 1.96 $ | — | — | — | — |
| Margins (% of revenue) | |||||||||
| Gross | 44.5 % | 43.3 % | 45.1 % | 44.2 % | 43.8 % | 43.9 % | 45.8 % | 44.7 % | ▲ +0.5 pt |
| Operating | 17.9 % | 14.6 % | 17.7 % | 18.2 % | 18.3 % | 19.9 % | 19.1 % | 18.5 % | ▲ +0.3 pt |
| Net | 12.7 % | 9.8 % | 12.8 % | 13.1 % | 12.9 % | 13.9 % | 13.4 % | 13.5 % | ▲ +0.3 pt |
| Balance sheet | |||||||||
| Assets | $10.01B | $10.15B | $10.40B | $10.41B | $10.59B | $10.74B | $10.74B | $10.71B | ▲ +2.9% |
| Liabilities | $3.58B | $3.53B | $3.44B | $3.39B | $3.42B | $3.54B | $3.51B | $3.44B | ▲ +1.6% |
| Equity | $6.43B | $6.62B | $6.97B | $7.02B | $7.17B | $7.20B | $7.22B | $7.27B | ▲ +3.5% |
| Cash | $155.18M | $171.70M | $279.70M | $319.20M | $423.70M | $439.60M | $482.30M | $531.10M | ▲ +66.4% |
| Capital | |||||||||
| Shares outstanding | 98.25M | 98.37M | 98.49M | 98.15M | 98.08M | 97.60M | 97.50M | 97.11M | ▼ -1.1% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.